您的位置: 专家智库 > >

国家自然科学基金(30672525)

作品数:2 被引量:3H指数:1
相关作者:崔景荣徐波李中军易文渊韩冬更多>>
相关机构:北京大学更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 1篇中文期刊文章

领域

  • 1篇医药卫生

主题

  • 1篇MULTID...
  • 1篇P-GLYC...
  • 1篇PHTHAL...
  • 1篇SUBSTI...
  • 1篇THALID...
  • 1篇DOXORU...

机构

  • 1篇北京大学

作者

  • 1篇吕卓远
  • 1篇杨亚平
  • 1篇李敏
  • 1篇韩冬
  • 1篇易文渊
  • 1篇李中军
  • 1篇徐波
  • 1篇崔景荣

传媒

  • 1篇Journa...

年份

  • 1篇2008
2 条 记 录,以下是 1-1
排序方式:
Synthesis and reversal effect of a novel N-substituted phthalimidesugar on doxorubicin resistant of human breast cancer cells
2008年
Thalidomide (α-N-phthalimido-glutarimide, TLD) is a kind of anti-angiogenic and anti-inflammatory drug, and showed effects in the treatment of several disease entities. In this study, the biological effects of a novel N-sugar substituted phthalimide (STA-35) on the regulation of multidrug resistance (MDR) to doxorubicin (ADR) were investigated. The proliferation of cancer cells was detected by a SRB assay. The activity of P-glycoprotein (P-gp) was determined by a Flow cytometry. The expression of P-gp was measured by western blotting. The results showed that STA-35 inhibited the proliferation of human breast cancer cell line MCF-7 and its ADR resistant cell line MCF-7/ADR, and the relative resistance was only 1.19. Meanwhile, STA-35 could sensitize the cytotoxicity of ADR in MCF-7/ADR cells. In addition, we found that STA-35 reduced the activity of P-gp by suppressing the P-gp expression, which was indicated by the increase in the accumulation of rhodamine 123 in MCF-7/ADR cells. These results suggested a promising application of STA-35 as the MDR reversing agent. The underlying mechanism of the effects might be attributed to the inhibition of P-gp.
易文渊李敏杨亚平吕卓远徐波韩冬李中军崔景荣
关键词:THALIDOMIDEPHTHALIMIDEP-GLYCOPROTEIN
共1页<1>
聚类工具0